GALNT3 and renal cell carcinoma: To further confirm that GALNT3 is essential in the metastasis of RCC, we first examined the expression of GALNT3 in a cohort of 142 patients with RCC, and consistent with the result obtained from the TCGA data set, low GALNT3 expression predicted a poorer DFS of patients with RCC (Fig. 5A).